RPG Life Sciences Limited (NSE:RPGLIFE)
2,641.20
-139.00 (-5.00%)
Oct 23, 2026, 1:49 PM IST
RPG Life Sciences Revenue
RPG Life Sciences had revenue of 1.96B INR in the quarter ending June 30, 2026, with 15.85% growth. This brings the company's total for the last twelve months to 7.34B, up 11.78% year-over-year. In the fiscal year ending March 31, 2026, RPG Life Sciences had annual revenue of 7.08B with 8.28% growth. That makes RPG Life Sciences the 24,615th largest company in the world by revenue and 1,503rd in India.
Revenue (ttm)
7.34B
Revenue Growth
+11.78%
P/S Ratio
6.26
Revenue / Employee
5.38M
Employees
1,366
Market Cap
43.68B
Revenue by Geography
- India 4.83B 68.3%
- Outside India 2.24B 31.7%
Fiscal year ended Mar 31, 2026 See the full RPG Life Sciences breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 7.08B | 541.30M | 8.28% |
| Mar 31, 2025 | 6.53B | 713.80M | 12.26% |
| Mar 31, 2024 | 5.82B | 692.40M | 13.50% |
| Mar 31, 2023 | 5.13B | 726.50M | 16.51% |
| Mar 31, 2022 | 4.40B | 510.20M | 13.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 50.04B |
| Akums Drugs and Pharmaceuticals | 45.04B |
| Aarti Pharmalabs | 19.69B |
| Sun Pharma Advanced Research Company | 19.09B |
| Indoco Remedies | 18.73B |
| Innova Captab | 17.49B |
| Solara Active Pharma Sciences | 15.35B |
| Orchid Pharma | 8.52B |
RPG Life Sciences News
- 2 months ago - RPG Life Sciences Quarterly report: Q1 2027 - Filings
- 2 months ago - RPG Life Sciences Slides: Q1 2027 - Filings
- 5 months ago - RPG Life Sciences Slides: Investor presentation - Filings
- 5 months ago - RPG Life Sciences Transcript: Q4 25/26 - Transcripts
- 5 months ago - RPG Life Sciences Quarterly report: Q4 2026 - Filings
- 5 months ago - RPG Life Sciences Slides: Q4 2026 - Filings
- 5 months ago - RPG Life Sciences Annual report: Q4 2026 - Filings
- 5 months ago - RPG Life Sciences surges 11% to Rs 2,254 despite 74% profit fall — EBITDA growth and Rs 24 dividend tell the real story - Business Upturn